Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the ...
News headlines UiPath (PATH) is set for significant growth as it joins the S&P MidCap 400 Index on January 2, 2026. The company has reported strong financial results, including its first GAAP ...
Abstract: Miniaturization is one of the main trends in the development of power supplies. High frequency helps to improve the flexibility of the magnetic field space of wireless power transfer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback